|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,670 KRW | -1.57% |
|
-5.58% | -9.35% |
| 2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
Jeil Pharmaceutical Co., Ltd. (KOSE:A002620) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,000 million worth of own shares pursuant to a trust agreement with Shinhan Investment Corp. The purpose behind the program is to stabilize the stock price.
Repurchases will continue until November 7, 2014. As of November 6, 2013, the company has 1,641,130 shares in directly owned treasury stock and 256,380 treasury stock under trust agreement.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.35% | 120M | |
| +21.28% | 44.4B | |
| +24.60% | 23.03B | |
| +19.22% | 15.14B | |
| +12.87% | 13.12B | |
| +44.67% | 11.85B | |
| -8.33% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.52B |
JEIL PHARMA HOLDINGS INC 